HFB-100204 is a humanized monoclonal antibody (mAb) targeting CXCR5. It reduces CXCR5+ immune cells, including B cells and Tfh cells, in the blood and spleen of hCXCR5 knockout mice. HFB-100204 is applicable for research focused on autoimmune diseases.
Target:
CXCR
* VAT and and shipping costs not included. Errors and price changes excepted